Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BF.5.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AP.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AK.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.98.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.1.13.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HK.34.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.124.1.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.203NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FY.8.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GY.9NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.7.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.254NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.36.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.36.12NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.21NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.122.2 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.79 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AQ.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.1.1.7NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.209NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.236NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.33NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XQNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.59NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.395NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.120.2.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.416.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.532NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.408NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XHNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.168NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.36.39NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.57NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AH.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.289NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.365NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.252NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.223NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.640.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.11 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.428NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.355NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.34.1.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.71 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.33.2 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.52NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.465NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.160.33NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.4.2.5 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used